Improve insulin sensitivity and promote fatty acid oxidation. SCFAs, like butyrate, activate AMPK in hepatocytes, reducing lipid accumulation and potentially alleviating hepatic steatosis and steatohepatitis in MASLD. This evidence concerns the gene INS and fatty liver disease.